Patents
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
04/2008
04/24/2008US20080097117 chemical intermediates for making antiinflammatory agents treating autoimmune disease; 1-[2-(Fluoren-3-yl)ethyl]-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine drug
04/24/2008US20080095788 Vaccines
04/23/2008CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives
04/16/2008EP1165549B1 C7 carbamoyloxy substituted taxanes as antitumor agents
04/09/2008CN101156861A Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
04/09/2008CN100379743C New oxabispidine compound useful in treatment of cardiac arrhythmias
04/09/2008CN100379739C Process for preparing azacycloalkanoylaminothiazoles
04/09/2008CN100379433C Method of treating diabetes by using plant argyrolobium roseum extract
04/03/2008US20080081050 Vaccine against streptococcus pneumoniae
04/02/2008EP1905449A2 Vaccines
04/02/2008CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives
04/02/2008CN100378074C 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
04/01/2008US7351858 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
04/01/2008US7351821 Oxabispidine compounds useful in the treatment of cardiac arrhythmias
04/01/2008CA2432578C Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
03/2008
03/26/2008CN100376567C Qinazoline derivatives as VEGF inhibitors
03/25/2008US7348324 Cyclic amine compounds as CCR5 antagonists
03/25/2008CA2343123C Active substance concentrate with formoterol, suitable for storage
03/20/2008US20080069842 Vaccines for Mycoplasma bovis and methods of use
03/19/2008CN101143898A Treatment of allergic conditions by use of IL-21
03/19/2008CN100375742C 4-oxoquinoline compounds and its use
03/18/2008US7345094 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer
03/18/2008US7345050 Imidazo(1,2a)pyridine or pyrazolo(2,3a)pyridine derivatives; Alzheimer's and Parkinson's Disease; nervous system, brain, and psychological disorders
03/18/2008CA2355776C Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
03/12/2008EP1897546A1 Combined compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid
03/11/2008US7342019 5, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists
03/06/2008US20080058297 Heterocyclic Compounds For Preventing And Treating Disorders Associated With Excessive Bone Loss
03/05/2008CN101137388A Anti-adhesion composites and methods os use thereof
03/05/2008CN100372845C Polycyclic compounds as potent alpha2-adrenoceptor antagonists
02/2008
02/27/2008EP1268470B1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
02/27/2008EP1163000B1 Vaccine against antigens from bacteriae
02/27/2008CN101130071A Vaccine
02/27/2008CN100371323C Cyanopyrrolidine derivatives
02/27/2008CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene
02/20/2008CN101125864A Heteroaromatic inhibitor for fructose-1,6-bisphosphatase
02/20/2008CN100369898C Nicotinamide derivates useful as p38 inhibitors
02/14/2008US20080039373 Pegylated Factor VII Glycoforms
02/13/2008EP1886994A1 Cyclic amine compounds as CCR5 antagonists
02/13/2008EP1572220B1 Antiviral properties of extracts of dichrostachys glomerata
02/13/2008EP1517679B1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
02/13/2008CN100367965C Use of bioactive metabolites of gepirone for the treatment of psychological disorders
02/05/2008US7326723 Autoimmune disease; antiinflammatory agents
02/05/2008US7326722 N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation and their application in therapy
01/2008
01/23/2008EP1880735A2 Vaccine
01/17/2008US20080015215 Diamine derivatives
01/17/2008US20080015206 Anti-cancer cyclopenta[G]quinazoline compounds
01/16/2008EP1878720A1 Process for preparing chiral bicycloprolinates as intermediates for the preparation of peptidomimetic protease inhibitors
01/16/2008EP1429754B1 Combination of selected opioids with muscarine antagonists for treating urinary incontinence
01/16/2008CN100362010C Mevalonic acid derivative
01/09/2008EP1876173A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors
01/09/2008CN101099865A A blocking monoclonal antibody to VLA-1 and its use for the treatment of vascular disorders
01/09/2008CN101099745A Methods and compositions for treating flaviviruses and pestiviruses
01/08/2008CA2296031C Novel spiroazabicyclic heterocyclic compounds
01/02/2008EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use
01/02/2008CN101098669A Component for forming a seal around an opening in the skin
01/02/2008CN101096337A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
12/2007
12/26/2007CN100356978C Novel exendin agonist formulations and methods administration thereof
12/20/2007US20070293527 1-Methyl-1,3,4,5,6,11b-hexahydro-2H-11-oxa-4a-aza-benzo[a]fluoren-1-ol; alpha 2C adrergic receptors; adrenergic blocking agents; central nervous system; cognition activators; antidepressants; anxiolytic agents; peripheral nervous syster; antidiabetic agents; hypertensive agents; Raynaud's disease
12/20/2007US20070292513 Pazopanib hydrochloride and synthesis, chemical intermediates, and dosage forms thereof; anticancer; colon cancer, breast cancer
12/19/2007CN100355755C Diazabicyclic central nervous system active agents
12/18/2007CA2418479C Prodrugs of betulinic acid derivatives for the treatment of cancer
12/12/2007EP1864975A2 Novel compounds
12/11/2007US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity
12/05/2007EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1656183B1 Treatment of male sexual dysfunction
12/05/2007EP1137642B1 Bis-sulfonamides
12/05/2007CN101081869A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081868A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081867A Humanized antibodies that recognize beta amyloid peptide
12/04/2007US7304083 2-iminoimidazole derivatives (2)
11/2007
11/28/2007EP1448201B1 N-(indolcarbonyl-)piperazine derivatives for the treatment of obesity
11/28/2007CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007CN100350919C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
11/27/2007US7301023 Immunosuppressants; grafting of organs; rheumatic diseases
11/22/2007US20070270427 vascular endothelial growth factor receptor inhibitors such as N2-(3-methyl-1H-indazol-6-yl)-N4-{3-[(methylsulfonyl)methyl]phenyl}-1,3,5-triazine-2,4-diamine trifluoroacetate, used as anticarcinogenic, antitumor or antiproliferative agents
11/21/2007CN100349904C Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
11/20/2007US7297701 Anti-cancer cyclopenta [G]quinazoline compounds
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007US7297353 For oral administration, injection and topical application; can eliminate the aseptic inflammations, edema, adhesion caused by aseptic inflammations, and stubborn pain, complex body disorders caused by aseptic inflammation, edema and adhesion
11/20/2007CA2300289C A pharmaceutical composition active in reducing production of mcp-1 protein
11/15/2007US20070265286 Quinazoline derivatives as VEGF inhibitors
11/15/2007US20070265282 Use of ticagrelor treating myocardial infarction, thrombotic stroke, angina and transient ischemic attacks
11/15/2007US20070264333 Method of treatment
11/14/2007CN100348580C Taxol enhancer compounds
11/08/2007US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents
11/07/2007CN101066952A Crystalline pharmaceutical
11/06/2007US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/01/2007WO2005000402A3 Anti-adhesion composites and methods os use thereof
10/2007
10/31/2007EP1849797A2 Peptidomimetic protease inhibitors
10/31/2007CN101062415A Use of IL-18 inhibitors
10/31/2007CN101062056A Low concentration of peroxide for treating or preventing vaginal infection
10/31/2007CN101062037A Thioxanthine derivatives, process for their preparation (variants), their use and composition containing them
10/31/2007CN100345844C Quinazoline derivatives for the treatment of tumours
10/25/2007US20070248614 Vaccination
10/17/2007EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007EP1204649B1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
10/17/2007CN100343252C Novel imidazopyridine compounds with therapeutic effect
10/16/2007US7282518 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
10/11/2007US20070238759 Novel Polymorph V of Torasemide
10/10/2007EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 32